You're assuming whoever tweeted that is correct. Here's one of the 189 trials. Perhaps it was in the non-daclatasvir arm. I don't recall cardiovascular issues being a side effect of ribavarin. http://clinicaltrials.gov/ct2/show/NCT01425970